Drug Discovery · New York, NY · Founded 2019 · Privately Held (backing)
Developer of targeted therapy drugs designed for the treatment of hematologic cancers. Ajax Therapeutics is based in New York, NY and was founded in 2019. Its last known valuation is $193 million. It has raised $143 million across 3 recorded rounds; the latest was a $95 million Series C in May 2024.
Last price · $/share
—
Implied valuation
$192.5M
Total raised
$143.0M
Last round
Later Stage VC (Series C)
May 2024
Team — not yet on record
No current team members for Ajax Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ajax Therapeutics with a free account
·The complete investor list: 11 names
·Watch Ajax Therapeutics: the Monday email on marks, rounds and moves
